(-0.15%) 5 014.88 points
(0.14%) 37 807 points
(-0.41%) 15 619 points
(0.00%) $82.69
(1.17%) $1.732
(0.32%) $2 396.10
(-0.12%) $28.37
(-0.36%) $950.80
(0.29%) $0.939
(0.55%) $11.05
(0.13%) $0.804
(-0.17%) $93.90
Live Chart Being Loaded With Signals
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease...
Stats | |
---|---|
Today's Volume | 3 964.00 |
Average Volume | 5 061.00 |
Market Cap | 5.50M |
EPS | $0 ( 2024-01-05 ) |
Next earnings date | ( $0 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.830 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-08-31 | Abrams Michael S | Buy | 20 584 | Warrants (right to buy) |
2023-08-31 | Abrams Michael S | Buy | 10 292 | Common Stock |
2023-08-31 | Norchi Terrence W | Buy | 13 724 | Warrants (right to buy) |
2023-08-31 | Norchi Terrence W | Buy | 6 862 | Common Stock |
2023-08-31 | Hicks Laurence | Buy | 20 584 | Warrants (right to buy) |
INSIDER POWER |
---|
100.00 |
Last 89 transactions |
Buy: 27 633 666 | Sell: 2 335 000 |
Arch Therapeutics, Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Arch Therapeutics, Inc. Financials
Annual | 2023 |
Revenue: | $75 724.00 |
Gross Profit: | $-2 439.00 (-3.22 %) |
EPS: | $-2.27 |
Q4 | 2023 |
Revenue: | $39 517.00 |
Gross Profit: | $16 236.00 (41.09 %) |
EPS: | $-0.520 |
Q3 | 2023 |
Revenue: | $13 293.00 |
Gross Profit: | $-5 236.00 (-39.39 %) |
EPS: | $-1.420 |
Q2 | 2023 |
Revenue: | $16 654.00 |
Gross Profit: | $-2 064.00 (-12.39 %) |
EPS: | $-0.800 |
Financial Reports:
No articles found.
Arch Therapeutics, Inc.
Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds. The company was founded in 2006 and is based in Framingham, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators